Eurofarma is featured in As Melhores da Dinheiro 2020
Published in: October 7, 2020
and updated in: November 4, 2021
Listen to the text
Stop the audio
São Paulo, October 2020 – Eurofarma, a Brazilian multinational with presence across 20 Latin American countries, was featured in the “As Melhores da Dinheiro 2020” award, promoted by IstoÉ Dinheiro magazine, announced at a virtual event last night, October 6. The company took second place in the overall ranking for the Pharmaceuticals, Hygiene and Cleaning Products sector.
In its 17th edition, the annual survey evaluates the operation and performance of companies from 23 sectors of the economy according to good management practices in five dimensions: financial management, corporate governance, social responsibility, human resources, innovation and quality.
About Eurofarma Group
As the first multinational pharmaceutical company with 100% Brazilian capital, the Eurofarma Group has been operating in the health industry since its establishment in 1972, producing and marketing innovative products and services to improve people’s quality of life. Focused on generating shared value, it operates in the areas of Prescription, Non-Prescription, and Generic Drugs, Hospital, Oncology and Veterinary. In Brazil alone, it offers 313 products, 649 dosage forms, serves 25 medical specialties and covers 89 therapeutic classes, which represent 81% of prescriptions in the brand market.
The Eurofarma Group has own operations in 20 countries, with an industrial park in Brazil and plants in 6 more Latin American countries. Reported sales totaled BRL 5.6 billion in 2019 and the Group employs over 7,000 employees.
EUROFARMA IN SOCIAL MEDIA
Facebook: @eurofarma | LinkedIn: @eurofarma
Instagram: @eurofarma_br | Twitter: @eurofarmaLab
In its 17th edition, the annual survey evaluates the operation and performance of companies from 23 sectors of the economy according to good management practices in five dimensions: financial management, corporate governance, social responsibility, human resources, innovation and quality.
About Eurofarma Group
As the first multinational pharmaceutical company with 100% Brazilian capital, the Eurofarma Group has been operating in the health industry since its establishment in 1972, producing and marketing innovative products and services to improve people’s quality of life. Focused on generating shared value, it operates in the areas of Prescription, Non-Prescription, and Generic Drugs, Hospital, Oncology and Veterinary. In Brazil alone, it offers 313 products, 649 dosage forms, serves 25 medical specialties and covers 89 therapeutic classes, which represent 81% of prescriptions in the brand market.
The Eurofarma Group has own operations in 20 countries, with an industrial park in Brazil and plants in 6 more Latin American countries. Reported sales totaled BRL 5.6 billion in 2019 and the Group employs over 7,000 employees.
EUROFARMA IN SOCIAL MEDIA
Facebook: @eurofarma | LinkedIn: @eurofarma
Instagram: @eurofarma_br | Twitter: @eurofarmaLab